On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Jean MacFadyen

ResearcherPublications, citations & collaboration network

Jean MacFadyen is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Jean MacFadyen have?

ScholarIQindexed works

Jean MacFadyen has 88 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Jean MacFadyen have?

ScholarIQcitation count

Jean MacFadyen has 37,551 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Jean MacFadyen?

ScholarIQh-index

Jean MacFadyen has an h-index of 56 in OpenAlex.

What is the i10-index of Jean MacFadyen?

ScholarIQi10-index

Jean MacFadyen has an i10-index of 68 in OpenAlex.

What is the OpenAlex record for Jean MacFadyen?

ScholarIQopenalex

The OpenAlex for Jean MacFadyen is on the source record.

What are the most-cited papers on Jean MacFadyen?

ScholarIQmost cited works
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paul M. Ridker, Brendan M. Everett, Tom Thurén, Jean MacFadyen, William H. Chang, Christie M. Ballantyne, Francisco Antônio Helfenstein Fonseca, José Carlos Nicolau, Wolfgang Köenig, Stefan D. Anker, John J.P. Kastelein, Jan H. Cornel, Prem Pais, Daniel Pella, Jacques Genest, Renata Cífková, Alberto Lorenzatti, Tamás Forster, Zhanna Kobalava, L Vida-Simiti, Marcus Flather, Hiroaki Shimokawa, Hisao Ogawa, Mikael Dellborg, Paulo R.F. Rossi, Roland P.T. Troquay, Peter Libby, Robert J. Glynn
New England Journal of Medicine. 20179,298 CitationsOPEN ACCESS
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
Paul M. Ridker, Jean MacFadyen, Tom Thurén, Brendan M Everett, Peter Libby, Robert J. Glynn, Paul M. Ridker, Alberto Lorenzatti, Henry Krum, George Varigos, Peter Siostrzonek, Peter Sinnaeve, Francisco Antônio Helfenstein Fonseca, José Carlos Nicolau, Nina Gotcheva, Jacques Genest, Yong Huo, Miguel Urina‐Triana, Davor Miličić, Renata Cífková, Riina Vettus, Wolfgang Köenig, S.D. Anker, Athanasios Manolis, Fernando Wyss, Tamás Forster, Axel F. Sigurðsson, Prem Pais, Alessandro Fucili, Hisao Ogawa, Hiroaki Shimokawa, Irina Veze, Birutė Petrauskienė, Leon Salvador, John J.P. Kastelein, Jan H. Cornel, Tor Ole Klemsdal, Félix Medina, Andrzej Budaj, L Vida-Simiti, Zhanna Kobalava, Petar Otašević, Daniel Pella, Mitja Lainščak, Ki‐Bae Seung, Patrick Commerford, Mikael Dellborg, Marc Y. Donath, Juey‐Jen Hwang, Hakan Kültürsay, Marcus Flather, Christie M. Ballantyne, Seth Bilazarian, William H. Chang, Cara East, Brendan Everett, Les B. Forgosh, Robert J. Glynn, Barry Harris, Peter Libby, M Ligueros, Tom Thurén, Erin A. Bohula, Bindu Charmarthi, Susan Cheng, Sherry Chou, Jacqueline Suk Danik, Graham T. McMahon, Bradley A. Maron, MingMing Ning, Benjamin A. Olenchock, Reena L. Pande, Todd S. Perlstein, Aruna D. Pradhan, Natalia S. Rost, Aneesh B. Singhal, Viviany R. Taqueti, Nancy Wei, Howard A. Burris, Angela Cioffi, Anne Marie Dalseg, Nilanjan Ghosh, Julie R. Gralow, Tina Mayer, Hope S. Rugo, Vance G. Fowler, Ajit P. Limaye, Sara E. Cosgrove, Donald P. Levine, Renato D. Lópes, John Scott, Tom Thurén, M Ligueros, Robert Hilkert, Georgia Tamesby, Carolyn Mickel, Brian Manning, Julian Woelcke, Monique Tan, S Manfreda
The Lancet. 20171,333 CitationsOPEN ACCESS
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
Paul M. Ridker, Brendan M. Everett, Aruna D. Pradhan, Jean MacFadyen, Daniel H. Solomon, Elaine Zaharris, Virak Mam, Ahmed Hasan, Yves Rosenberg, Erin Iturriaga, Milan Gupta, Michelle Tsigoulis, Subodh Verma, Michael Clearfield, Peter Libby, Samuel Z. Goldhaber, Roger L. Seagle, Cyril Ofori, Mohammad G. Saklayen, Samuel Butman, Narendra Singh, Michel Le May, Olivier F. Bertrand, James Johnston, Nina P. Paynter, Robert J. Glynn
New England Journal of Medicine. 20181,308 CitationsOPEN ACCESS
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
Paul M. Ridker, Jean MacFadyen, Brendan M Everett, Peter Libby, Tom Thurén, Robert J. Glynn, Paul M. Ridker, Jean MacFadyen, Brendan M Everett, Peter Libby, Tom Thurén, Robert J. Glynn, John J.P. Kastelein, Wolfgang Köenig, Jacques Genest, Alberto Lorenzatti, George Varigos, Peter Siostrzonek, Peter Sinnaeve, Francisco Antônio Helfenstein Fonseca, José Carlos Nicolau, Nina Gotcheva, Yong Huo, Miguel Urina‐Triana, Davor Miličić, Renata Cífková, Riina Vettus, S.D. Anker, Athanasios Manolis, Fernando Wyss, Tamás Forster, Axel F. Sigurðsson, Prem Pais, Alessandro Fucili, Hisao Ogawa, Hiroaki Shimokawa, Irina Veze, Birutė Petrauskienė, Leon Salvador, Jan H. Cornel, Tor Ole Klemsdal, Félix Medina, Andrzej Budaj, L Vida-Simiti, Zhanna Kobalava, Petar Otašević, Daniel Pella, Mitja Lainščak, Ki‐Bae Seung, Patrick Commerford, Mikael Dellborg, Marc Y. Donath, Juey‐Jen Hwang, Hakan Kültürsay, Marcus Flather, Christie M. Ballantyne, Seth Bilazarian, William H. Chang, Cara East, Les B. Forgosh, Barry Harris, M Ligueros
The Lancet. 2017903 CitationsOPEN ACCESS
Adverse Effects of Low-Dose Methotrexate
Daniel H. Solomon, Robert J. Glynn, Elizabeth W. Karlson, Fengxin Lu, Cassandra Corrigan, Josh Colls, Chang Xu, Jean MacFadyen, Medha Barbhaiya, Nancy Berliner, Paul F. Dellaripa, Brendan M. Everett, Aruna D. Pradhan, Sarah P. Hammond, Meredith Murray, Deepak A. Rao, Susan Y. Ritter, Anna Rutherford, Jeffrey A. Sparks, Jackie Stratton, Dong Hyun Suh, Sara K. Tedeschi, Kathleen M.M. Vanni, Nina P. Paynter, Paul M. Ridker
Annals of Internal Medicine. 2020225 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account